Important Notice: Limited Web Access Dec 16 to 18, 2016

AIChE will undertake a routine upgrade of our digital infrastructure over the weekend of December 16-18, 2016. During this period access to certain areas of the website will be limited. Additional information will be forthcoming shortly.

Progress In Quality by Design Implementation In Fda's Office of New Drug Quality Assessment

  • Type:
    Conference Presentation
  • Conference Type:
    AIChE Annual Meeting
  • Presentation Date:
    October 17, 2011
  • Skill Level:
    Intermediate
  • PDHs:
    0.50

Share This Post:

You will be able to download and print a certificate for PDH credits once the content has been viewed. If you have already viewed this content, please click here to login.

Since the launch of the Office of New Drug Quality Assessment (ONDQA) CMC pilot program in July 2005, over 40 Quality by Design (QbD) containing applications have been submitted, reviewed, and approved by ONDQA, both within and outside of the pilot. Although challenges still remain, many approaches for preparation and review of QbD containing applications have been established and efforts are underway toward international harmonization. This presentation will discuss the progress made to date in QbD and remaining scientific and regulatory challenges. Additionally, an overview will be given of harmonization efforts, including the recently announced pilot between FDA and the European Medicines Agency (EMA) for QbD containing applications.
Presenter(s): 

Checkout

Checkout

Do you already own this?

Log In for instructions on accessing this content.

Pricing

AIChE Member Credits 0.5
AIChE Members $15.00
AIChE Undergraduate Student Members Free
AIChE Graduate Student Members Free
Non-Members $25.00